NC H659

Allows supervising physicians to delegate any patient care services they deem appropriate to licensed pharmacists through collaborative practice agreements, broadening pharmacist authority beyond previously defined drug therapy management.

Establishes a registry maintained by the North Carolina Board of Pharmacy for clinical pharmacist practitioners and requires unique identification numbers for each participating pharmacist.

Permits clinical pharmacist practitioners to conduct drug substitutions within the same therapeutic class if authorized by the supervising physician, with documentation and periodic physician review required.

Requires the North Carolina Medical Board and Board of Pharmacy to adopt joint rules governing collaborative practice within six months of statutory changes, with compliance responsibility assigned to the Board of Pharmacy.

Sets registration fees not to exceed $50.00 for initial application and $50.00 for annual renewal, and becomes effective October 1, 2019.